Vaginal Misoprostol for Cervical Ripening Prior to Endometrial Biopsy
Status:
Withdrawn
Trial end date:
2012-09-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether using Misoprostol vaginally before an
office endometrial biopsy is performed, will make it easier, more successful and less painful
to do the procedure.
The investigators' hypothesis is that vaginal Misoprostol 12 hours prior to endometrial
biopsy will increase the ease of performing office endometrial biopsy by reducing the need to
use a tenaculum or a cervical dilator to achieve passage of a biopsy pipelle.